Article

jdsupra.com on 2017-07-27 01:26

Bevacizumab Biosimilar Update

There has been some recent activity regarding proposed biosimilars to Roche’s Avastin (bevacizumab). Avastin is indicated for the treatment of various ...

JD Supra

Related news

Biocon Ltd Launches Bevacizumab Biosimilar in India jdsupra.com
India
Pfizer Receives European Approval For Avastin® (Bevacizumab) Biosimilar jdsupra.com
California , United States , Switzerland
FDA Advisory Committee to Hold Public Meetings on Amgen’s Proposed Bevacizumab Biosimilar and Mylan’s Proposed Trastuzumab Biosimilar jdsupra.com
Maryland , Silver Springs , Manage
Coherus Update on Biosimilar Pipeline jdsupra.com
Update on Biosimilar Launches and Development jdsupra.com
Update on biosimilar launches and development jdsupra.com
Legislative Update: State Biosimilar Substitution Laws jdsupra.com
FDA Accepts Samsung Bioepis’s Bevacizumab Biosimilar (SB8)jdsupra.com
California , United States , Switzerland
Celltrion’s Bevacizumab Biosimilar Approved by FDA jdsupra.com
Japan , United States
Genentech Sues Centus Over Proposed Bevacizumab Biosimilar jdsupra.com
Texas , Jilin , Kyowa-cho , Sues
FDA Defers Decision on Bevacizumab Biosimilar jdsupra.com
Remicade® Update: Double Patenting Redoubles in Post-Gilead Biosimilar Case jdsupra.com
Update on Biosimilar Testing: Cinfa, Mylan/Biocon, Sandoz jdsupra.com
Biosimilars Update -- Pfizer's Proposed Epogen®/Procrit® Biosimilar Recommended for Approval jdsupra.com
FDA Accepts Bio-Thera’s BLA for Bevacizumab Biosimilar jdsupra.com
Brazil , China
FDA Issues CRL for Biocon/Viatris Bevacizumab Biosimilar jdsupra.com
Prestige Biopharma and Intas Pharmaceuticals Partner on Bevacizumab Biosimilar jdsupra.com
GBevacizumab Biosimilar Market 2021 Applications and SWOT Analysis to 2028 galleonnews.com
Viatris and Biocon Biologics Launch Bevacizumab Biosimilar ABEVMY in Canada jdsupra.com
Canada
Amneal Launches Bevacizumab Biosimilar in the United States jdsupra.com
United States